Literature DB >> 18344548

Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.

Jonas Marschall1, Denis Agniel, Victoria J Fraser, Joshua Doherty, David K Warren.   

Abstract

BACKGROUND: A considerable number of gram-negative bacteraemias occur outside intensive care units (ICUs). Inadequate antibiotic therapy in ICUs has been associated with adverse outcomes; however, there are no prospective studies in non-ICU patients.
METHODS: A 6 month (1 August 2006-31 January 2007), prospective cohort study of non-ICU patients with gram-negative bacteraemia in a tertiary-care hospital was performed. Inadequate empirical antibiotic therapy was defined as no antibiotic or starting a non-susceptible antibiotic within 24 h after the initial positive blood culture.
RESULTS: Two hundred and fifty non-ICU patients had gram-negative bacteraemia. The mean age was 56.4 (+/-16.1) years. The predominant bacteria in monomicrobial infections were Escherichia coli (24%), Klebsiella pneumoniae (18%) and Pseudomonas aeruginosa (8%). Sixty-one (24%) patients had polymicrobial bacteraemia. Seventy patients (28%) required ICU transfer and 35 (14%) died. Seventy-nine (31.6%) received inadequate empirical antibiotic therapy. These patients were more likely to have a hospital-acquired infection [odds ratio (OR) = 1.99, 95% confidence interval (CI) = 1.11-3.56, P = 0.02] and less likely to have E. coli monomicrobial bacteraemia [OR 0.40 (95% CI 0.19-0.86), P = 0.02]. There were no differences in occurrence of sepsis [72 (91.1%) patients with inadequate versus 159 (93.0%) with adequate therapy; P = 0.6], ICU transfer [20 (25.3%) versus 50 (29.2%); P = 0.5], post-bacteraemia length of stay (median = 6.8 versus 6.1 days; P = 0.09) or death [11 (13.9%) versus 24 (14.0%); P = 1.0].
CONCLUSIONS: Nearly one-third of the non-ICU patients with gram-negative bacteraemia received inadequate empirical antibiotic therapy. There was no difference in adverse outcomes between patients receiving inadequate or adequate therapy in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344548      PMCID: PMC2902848          DOI: 10.1093/jac/dkn104

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  39 in total

Review 1.  Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital.

Authors:  O Uzun; H E Akalin; M Hayran; S Unal
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome.

Authors:  M Garrouste-Orgeas; S Chevret; J L Mainardi; J F Timsit; B Misset; J Carlet
Journal:  J Hosp Infect       Date:  2000-03       Impact factor: 3.926

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study.

Authors:  D K Warren; J E Zack; A M Elward; M J Cox; V J Fraser
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Authors:  Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

6.  Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results.

Authors:  Emilio Bouza; Dolores Sousa; Patricia Muñoz; Marta Rodríguez-Créixems; Carlos Fron; Juan Garcia Lechuz
Journal:  Clin Infect Dis       Date:  2004-09-24       Impact factor: 9.079

7.  Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Authors:  Stephan Harbarth; Jorge Garbino; Jérome Pugin; Jacques A Romand; Daniel Lew; Didier Pittet
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

8.  Computerized antimicrobial decision support: an offline evaluation of a database-driven empiric antimicrobial guidance program in hospitalized patients with a bloodstream infection.

Authors:  Charles J Mullett; John G Thomas; Connie L Smith; Arif R Sarwari; Rashida A Khakoo
Journal:  Int J Med Inform       Date:  2004-06-15       Impact factor: 4.046

Review 9.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

10.  Epidemiology and outcome of nosocomial and community-onset bloodstream infection.

Authors:  D J Diekema; S E Beekmann; K C Chapin; K A Morel; E Munson; G V Doern
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  13 in total

Review 1.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

2.  Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study.

Authors:  Monika Pogorzelska; Patricia W Stone; Elaine L Larson
Journal:  Am J Infect Control       Date:  2012-10       Impact factor: 2.918

3.  Economic burden of healthcare-associated infections: an American perspective.

Authors:  Patricia W Stone
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2009-10       Impact factor: 2.217

4.  Translating infection control guidelines into practice: implementation process within a health care institution.

Authors:  Victoria H Raveis; Laurie J Conway; Mayuko Uchida; Monika Pogorzelska-Maziarz; Elaine L Larson; Patricia W Stone
Journal:  Qual Health Res       Date:  2014-03-05

5.  Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation.

Authors:  Deverick J Anderson; Becky Miller; Ruchit Marfatia; Richard Drew
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04-13       Impact factor: 3.254

Review 6.  Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis.

Authors:  Kristel Marquet; An Liesenborgs; Jochen Bergs; Arthur Vleugels; Neree Claes
Journal:  Crit Care       Date:  2015-02-16       Impact factor: 9.097

7.  The impact of inappropriate antibiotics on bacteremia patients in a community hospital in Taiwan: an emphasis on the impact of referral information for cases from a hospital affiliated nursing home.

Authors:  Chih-Jen Yang; Yu-Chieh Chung; Tun-Chieh Chen; Hsu-Liang Chang; Ying-Ming Tsai; Ming-Shyan Huang; Yen-Hsu Chen; Po-Liang Lu
Journal:  BMC Infect Dis       Date:  2013-10-24       Impact factor: 3.090

8.  Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department.

Authors:  Ioannis M Zacharioudakis; Fainareti N Zervou; Fadi Shehadeh; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

9.  Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen.

Authors:  M Pogorzelska-Maziarz; E Y Furuya; E L Larson
Journal:  Epidemiol Infect       Date:  2013-02-21       Impact factor: 4.434

10.  Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.

Authors:  Rebekah W Moehring; Richard Sloane; Luke F Chen; Emily C Smathers; Kenneth E Schmader; Vance G Fowler; David J Weber; Daniel J Sexton; Deverick J Anderson
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.